Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV, offering services including clinical trial management, regulatory affairs, patient recruitment and retention, data management, medical writing, pharmacovigilance, bioanalytical laboratory services, and imaging capabilities. Medpace serves small and midsize biopharmaceutical sponsors that lack internal capacity to conduct trials independently, as well as larger pharmaceutical firms seeking specialized expertise. Operating across North America, Europe, Asia, South America, Africa, and Australia, Medpace combines scientific expertise with operational excellence to accelerate drug development timelines. Founded in 1992 and headquartered in Cincinnati, Ohio, the company supports the global outsourcing environment for clinical research and development, helping sponsors navigate complex regulatory requirements and bring new therapeutics to market efficiently.